Uses AI systems in screenings, blood test and other diagnostic procedures to test for cancer.
Description
Freenome is developing next-generation blood tests for early cancer detection, powered by our multiomics platform. Freenome aims to detect cancer in its earliest stages and subsequently develop new treatments.